MENDHAM, N.J., June 8 /PRNewswire-FirstCall/ -- David M. Goldenberg,
Sc.D., M.D., founder and Chairman of the Board of Directors of Immunomedics
(Nasdaq: IMMU) announced that on June 3, 2005, he transferred shares of
Immunomedics stock to trusts for the benefit of his family, as part of an
ongoing estate planning program, which was begun several years ago. The
transfers were not sales in the open market, but were in the form of a gift
and a noncash transfer.
Dr. Goldenberg, his wife, Cynthia Sullivan, the Company's President and
Chief Executive Officer, and his issue are the only beneficial owners of the
intra-family trusts. The transactions were implemented upon the advice of Dr.
Goldenberg's estate planning counsel.
Media Contact:
Chau Cheng 973 605 8200 x123
SOURCE David M. Goldenberg
 back to top
Related links:
http://www.immunomedics.com
Company News On-Call:
http://www.prnewswire.com/comp/113121.html
CONTACT:
Media, Chau Cheng, +1-973-605-8200 x123, for
David M. Goldenberg
|
